Kv Channel Interacting Protein 3, Calsenilin (KCNIP3) ELISA Kits

KCNIP3 encodes a member of the family of voltage-gated potassium (Kv) channel-interacting proteins, which belong to the recoverin branch of the EF-hand superfamily. Additionally we are shipping Kv Channel Interacting Protein 3, Calsenilin Antibodies (154) and Kv Channel Interacting Protein 3, Calsenilin Proteins (13) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
KCNIP3 30818 Q9Y2W7
KCNIP3 56461 Q9QXT8
KCNIP3 65199 Q9JM47
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top Kv Channel Interacting Protein 3, Calsenilin ELISA Kits at antibodies-online.com

Showing 5 out of 10 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Supplier Delivery Price Details
Human
  2 x 96 Tests Log in to see 2 to 3 Days
$480.00
Details
Rat < 46.9 pg/mL 78 pg/mL - 5000 pg/mL   96 Tests Log in to see 11 to 18 Days
$810.17
Details
Human < 0.094 ng/mL 0.156 ng/mL - 10 ng/mL   96 Tests Log in to see 11 to 18 Days
$810.17
Details
Mouse
  96 Tests Log in to see 15 to 18 Days
$875.60
Details
Cow
  96 Tests Log in to see 15 to 18 Days
$1,029.60
Details

More ELISA Kits for Kv Channel Interacting Protein 3, Calsenilin Interaction Partners

Human Kv Channel Interacting Protein 3, Calsenilin (KCNIP3) interaction partners

  1. Data show that Ca(2+)-binding protein (KChIP3) levels regulate baseline Mucin 5AC (MUC5AC) secretion.

  2. this study shows that human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway

  3. TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets.

  4. targeting SmgGDS induces nucleolar stress, resulting in profound loss of DREAM target gene expression required for G1, S and G2 progression, and ultimately resulting in cell cycle arrest.

  5. Disruption of DREAM and RB-E2F complexes by oncoproteins from DNA tumor viruses leads to upregulation of cell cycle genes and impairs growth-inhibiting pathways, including the p53-mediated downregulation of cell cycle genes. [review]

  6. This study shows the application of hydrogen-deuterium exchange mass spectrometry and site-directed mutagenesis to investigate the Ca(2+) binding properties and the subsequent conformational changes of full-length DREAM. EF-hands undergo large conformation changes upon calcium binding even though the EF-1 hand is not capable of binding to Ca(2+).

  7. Our approach yields high confidence ranked target gene maps for TP53, DREAM, MMB-FOXM1 and RB-E2F and enables prediction and distinction of CC regulation. A web-based atlas at www.targetgenereg.org enables assessing the regulation of any human gene of interest.

  8. downregulation of these genes through the p53-p21-DREAM-CDE/CHR pathway appears to be a principal mechanism for G2/M cell cycle arrest by p53.

  9. The aim of this study was to investigate somatic mutations and DREAM gene expression in human multinodular goiter

  10. Imatinib induces GIST cell quiescence in vivo and that this process also involves the DREAM complex.

  11. Our results support the hypothesis that KChIPs enhances Kv4.2 functional expression by a 1 : 1 suppression of the N-terminal FERN domain and by producing additional positive regulatory effects on functional channel expression.

  12. GCM1-directed villous trophoblast differentiation is repressed by DREAM

  13. p53 can repress transcription of cell cycle genes through a p21(WAF1/CIP1)-dependent switch from MMB to DREAM protein complex binding at CHR promoter elements.

  14. Genetic variation in the DREAM pathway genes was associated with the extent of pain reporting in a population-based cohort.

  15. The potassium channel interacting protein 3 (DREAM/KChIP3) heterodimerizes with and regulates calmodulin function.

  16. expression of calsenilin leads to a disruption of presenilin 1/gamma-secretase-mediated epsilon-cleavage of N-cadherin, which results in the significant accumulation of N-cadherin C-terminal fragment 1

  17. The results show that continued human papillomavirus 16 E6/E7 expression is necessary in cervical cancer cells to prevent cell-cycle arrest by a repressive p130-DREAM complex.

  18. These findings suggest that calsenilin degradation is primarily mediated by the UPP and that impairment in the UPP may contribute to the involvement of calsenilin in disease-associated neurodegeneration.

  19. apoptosis inducers as diverse as oncoprotein inhibitors and cell death receptor activators trigger Hrk expression via blockade of DREAM in leukemia cells

  20. Immunoreactivity of calsenilin in the hippocampus derived from an epilepsy patient is significantly decreased compared with normal brain.

Mouse (Murine) Kv Channel Interacting Protein 3, Calsenilin (KCNIP3) interaction partners

  1. DREAM inhibition markedly improves ATF6 processing in the hippocampus and that it might contribute to a delay in memory decline in Huntington mice.

  2. Genome-wide analysis of trigeminal neurons in daDREAM transgenic mice identified cathepsin L and the monoglyceride lipase as two new DREAM transcriptional targets related to pain.

  3. Our findings demonstrate for the first time that DREAM plays an important role in thrombosis and hemostasis in mice.

  4. association of PS1 carboxyl peptide (residues 445-467, HL9) with DREAM is calcium dependent and stabilized by a cluster of three aromatic residues: F462 and F465 from PS1 and F252 from DREAM.

  5. DREAM plays an important role in structural plasticity in the hippocampus.

  6. Terbium(III) binding preserves the folding state of DREAM with minimal changes to overall structure of DREAM.

  7. Results presented in this study show for the first time that down-regulation of DREAM promotes the degeneration of RGCs, amacrine cells, and bipolar cells.

  8. The association of calcium-bound calmodulin (CaM) with DREAM is mediated by a short amphipathic amino acid sequence located between residues 29 and 44 on DREAM.

  9. The protein DREAM decreases development of L-DOPA-induced dyskinesia in mice and reduces L-DOPA-induced expression of FosB, phosphoacetylated histone H3, and dynorphin-B in the striatum

  10. NS5806 directly interacts with KChIP3 and modulates the interactions between this calcium-binding protein and the T1 domain of the Kv4.3 channels through reorientation of helix 10 on KChIP3

  11. These results provide the first evidence that DR/C/K3 plays a timing-dependent role in estradiol regulation of learning, memory, and plasticity.

  12. studies define the critical opposing functions of DREAM and USF1 in inhibiting and inducing A20 expression

  13. DREAM is a major master switch transcription factor.

  14. GCM1-directed villous trophoblast differentiation is repressed by DREAM

  15. Expression of DREAM in neuroblastoma cells enhances cisplatin mediated caspase-3 activity.

  16. Restoring CANT1 levels in neuroblastoma clones recovered the phenotype, thus confirming a key role of CANT1, and of the regulation of its gene by DREAM, in the control of protein synthesis and degradation

  17. In cardiomyocytes, [Ca2+]i-activated calmodulin kinase II (CaMKII) activates downstreamregulatory element (DRE) binding transcription factor DREAM, which consequently suppresses the expression of L-type calcium channel 1C-subunit gene (Cacna1c).

  18. Sumoylation regulates the nuclear localization of DREAM in differentiated neurons.

  19. endogenous BDNF is involved in spinal sensitization following inflammation and blockade of BDNF induction in DREAM transgenic mice underlies the failure to develop spinal sensitization

  20. Results demonstrate that DREAM plays a novel role in postsynaptic modulation of the NMDA receptor, and contributes to synaptic plasticity and behavioral memory.

Zebrafish Kv Channel Interacting Protein 3, Calsenilin (KCNIP3) interaction partners

  1. zebrafish calsenilin is involved in endocrine cell differentiation and morphogenesis within the pancreas

Kv Channel Interacting Protein 3, Calsenilin (KCNIP3) Antigen Profile

Antigen Summary

This gene encodes a member of the family of voltage-gated potassium (Kv) channel-interacting proteins, which belong to the recoverin branch of the EF-hand superfamily. Members of this family are small calcium binding proteins containing EF-hand-like domains. They are integral subunit components of native Kv4 channel complexes that may regulate A-type currents, and hence neuronal excitability, in response to changes in intracellular calcium. The encoded protein also functions as a calcium-regulated transcriptional repressor, and interacts with presenilins. Alternatively spliced transcript variants encoding different isoforms have been described.

Gene names and symbols associated with KCNIP3

  • potassium voltage-gated channel interacting protein 3 (KCNIP3) antibody
  • Kv channel-interacting protein 4 (LOC5568664) antibody
  • calsenilin (CpipJ_CPIJ002549) antibody
  • calsenilin (Tsp_05009) antibody
  • Kv channel interacting protein 3, calsenilin (Kcnip3) antibody
  • potassium voltage-gated channel interacting protein 3 (Kcnip3) antibody
  • Kv channel interacting protein 3b, calsenilin (kcnip3b) antibody
  • Kv channel interacting protein 3, calsenilin (KCNIP3) antibody
  • potassium voltage-gated channel interacting protein 3 (kcnip3) antibody
  • 4933407H12Rik antibody
  • AI413860 antibody
  • csen antibody
  • Dream antibody
  • im:7145308 antibody
  • KChIP3 antibody
  • KCNIP3 antibody
  • R74849 antibody
  • rKChIP3 antibody
  • zgc:73306 antibody

Protein level used designations for KCNIP3

A-type potassium channel modulatory protein 3 , DRE-antagonist modulator , calsenilin , calsenilin, presenilin-binding protein, EF hand transcription factor , kv channel-interacting protein 3 , potassium channel interacting protein 3 , calsenilin, presenilin binding protein, EF hand transcription factor , A-type potassium channel modulating protein 3 , KChIP3 , calsenilin presenilin-binding protein EF hand transcription factor , calsenilin, presenilin-binding protein, EF hand transcription fa , downstream regulatory element-antagonist modulator , Kv channel interacting protein 3, calsenilin

GENE ID SPECIES
30818 Homo sapiens
5568664 Aedes aegypti
6033823 Culex quinquefasciatus
10912880 Trichinella spiralis
56461 Mus musculus
65199 Rattus norvegicus
393755 Danio rerio
459401 Pan troglodytes
513316 Bos taurus
704307 Macaca mulatta
100135241 Xenopus (Silurana) tropicalis
100856050 Canis lupus familiaris
100717101 Cavia porcellus
Selected quality suppliers for Kv Channel Interacting Protein 3, Calsenilin (KCNIP3) ELISA Kits
Did you look for something else?